Geneva, June 20 -- International Clinical Trials Registry received information related to the study (NCT07020351) titled 'A Master Protocol of Multiple Interventions for the Treatment of Adults With Moderate-to-Severe Atopic Dermatitis' on June 6.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Screening. Masking: None (Open Label).
Primary Sponsor: Eli Lilly and Company
Condition:
Atopic Dermatitis
Intervention:
Drug: LY3454738
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: June 21, 2023
Target Sample Size: 317
Countries of Recruitment:
United States
Canada
China
Hungary
Japan
Korea, Republic of
Mexico
Poland
Taiwan
Canad...